Prevalence of multimorbidity up in rheumatoid arthritis
Patients with rheumatoid arthritis (RA) have an increased prevalence of multimorbidity, according to a study recently published in RMD Open.
May 17, 2022
0
2
Patients with rheumatoid arthritis (RA) have an increased prevalence of multimorbidity, according to a study recently published in RMD Open.
May 17, 2022
0
2
More than a fifth of patients with chronic medical conditions may still have insufficient levels of antibodies to fight COVID-19 even after a second mRNA vaccine dose. Both the Pfizer and the Moderna vaccines are mRNA vaccines. ...
Jan 17, 2022
0
18
Lung disease caused by a new drug for cancers—including metastatic or advanced breast cancer—can be effectively treated using approaches that focus on early detection and prompt management, according to a study published ...
Aug 11, 2022
0
20
Could healthy fats found in nuts and fish slow the progression of potentially deadly lung scarring known as pulmonary fibrosis and delay the need for lung transplants?
Jan 2, 2024
0
38
A Wednesday morning session will explore the inhalational exposures and respiratory outcomes of military deployment to Iraq and Afghanistan. Presenters will review current knowledge on complex inhalational exposures, epidemiologic ...
May 18, 2011
1
0
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. ...
Sep 21, 2022
0
2
Patients with idiopathic pulmonary fibrosis (IPF) who report treatment for gastroespophageal reflux (GER) appear to have longer survival than IPF patients who are not treated for GERD, according to a new study from the University ...
Jul 19, 2011
0
0
(HealthDay)—Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer (NSCLC) with a specific genetic mutation (epidermal growth factor receptor ...
Jul 14, 2015
0
10
(HealthDay)—A pair of drugs offers new hope to patients with a progressive, fatal disease that robs their breath by scarring the lungs, according to clinical trial results.
May 18, 2014
0
0
An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary ...
Oct 22, 2018
0
15